To detect breast cancer when it can be cured
Focusing on persons’ well-being, our solution is non-ionizing (free from X-rays), meaning there is no radiation risk
MammoWave is made of an aluminium cylindrical hub, containing two antennas that operate in the microwave band (1-9 GHz) at a very low power (1mW). MammoWave allows to illuminate the breast using an electromagnetic fields and to measure the correspondent scattered fields. The measured fields is then processed field through a dedicated algorithm, obtaining the image of the breast. Microwave imaging exploits the contrast in the dielectric properties at microwave frequencies of normal tissues and tissues with lesions. MammoWave software uses a novel, fast, and accurate imaging algorithm (based on the Huygens Principle) which highlights tissues dielectric inhomogeneities.
The first MammoWave feasibility clinical trials ended in March 2020.
The trials, authorized by Italian Ministry of Health and by the Ethical Committee of Regione Umbria, Italy, have been carried out at Perugia Hospital “Azienda Ospedaliera S. Maria della Misericordia” (clinical investigator: Dr. Michele Duranti) and at Foligno Hospital (clinical investigator: Dr. Riccardo Loretoni).
Thanks to the H2020 SMEINST Phase 2 funding, in 2021 UBT completed an interational multicentric trials at the following Hospitals: Humanitas Milano (clinical investigator: Dr. Chiara Bernardi); San Martino Genova (clinical investigator: Dr. Alberto Tagliafico and Dr. Massimo Calabrese); Toledo Hospital (clinical investigator: Dr. Cristina Romero) in Spain. Clinical trials results have been published in numerous scientific journals.
Images of some test cases can be found here
Performances when using AI can be found here.
Do not hesitate to contact us. We will be happy to inform you about our innovative medical devices